Published in Nucleic Acids Res on November 29, 2016
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46
Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol (2004) 101.91
Comprehensive molecular portraits of human breast tumours. Nature (2012) 47.39
Comprehensive molecular characterization of human colon and rectal cancer. Nature (2012) 34.13
Cancer genome landscapes. Science (2013) 25.33
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science (2006) 24.54
Missing value estimation methods for DNA microarrays. Bioinformatics (2001) 20.84
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature (2012) 20.47
Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature (2013) 20.16
The human disease network. Proc Natl Acad Sci U S A (2007) 19.58
The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol (2004) 19.38
The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet (2009) 18.90
Comprehensive genomic characterization of squamous cell lung cancers. Nature (2012) 18.90
Mutational landscape and significance across 12 major cancer types. Nature (2013) 14.91
Integrated genomic characterization of endometrial carcinoma. Nature (2013) 14.29
Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature (2013) 13.60
The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet (2013) 11.29
Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer (2006) 11.22
Comprehensive molecular profiling of lung adenocarcinoma. Nature (2014) 11.02
Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet (2006) 10.47
Cancer and the chemokine network. Nat Rev Cancer (2004) 10.27
Epigenetic stem cell signature in cancer. Nat Genet (2006) 9.62
CpG islands and the regulation of transcription. Genes Dev (2011) 9.50
A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet (2007) 9.47
Pathway Commons, a web resource for biological pathway data. Nucleic Acids Res (2010) 9.18
Comprehensive molecular characterization of urothelial bladder carcinoma. Nature (2014) 8.48
Epigenetic modifications and human disease. Nat Biotechnol (2010) 7.29
Mutual exclusivity analysis identifies oncogenic network modules. Genome Res (2011) 7.22
WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer (2013) 6.64
Integrated genomic characterization of papillary thyroid carcinoma. Cell (2014) 6.05
Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. Genome Res (2010) 6.03
Protein networks in disease. Genome Res (2008) 5.65
The importance of bottlenecks in protein networks: correlation with gene essentiality and expression dynamics. PLoS Comput Biol (2007) 5.63
Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature (2015) 5.50
Human aging-associated DNA hypermethylation occurs preferentially at bivalent chromatin domains. Genome Res (2010) 5.08
A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data. Bioinformatics (2012) 4.95
An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer. Genome Biol (2007) 4.33
Global topological features of cancer proteins in the human interactome. Bioinformatics (2006) 4.17
Epigenetics as a unifying principle in the aetiology of complex traits and diseases. Nature (2010) 4.04
Network-based stratification of tumor mutations. Nat Methods (2013) 3.12
Interplay between the cancer genome and epigenome. Cell (2013) 3.05
Interactome-transcriptome analysis reveals the high centrality of genes differentially expressed in lung cancer tissues. Bioinformatics (2005) 2.82
Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy. Nature (2015) 1.98
Age-associated epigenetic drift: implications, and a case of epigenetic thrift? Hum Mol Genet (2013) 1.76
CoMEt: a statistical approach to identify combinations of mutually exclusive alterations in cancer. Genome Biol (2015) 1.64
Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns. Genome Biol (2012) 1.63
Wnt signaling in adult intestinal stem cells and cancer. Cell Signal (2013) 1.62
Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis. Oncogene (2006) 1.56
Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer. Nat Rev Genet (2013) 1.53
An integrative network algorithm identifies age-associated differential methylation interactome hotspots targeting stem-cell differentiation pathways. Sci Rep (2013) 1.26
Improved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modules. BMC Cancer (2010) 1.22
Pathway and network analysis of cancer genomes. Nat Methods (2015) 1.17
Dissecting the expression landscape of RNA-binding proteins in human cancers. Genome Biol (2014) 1.17
Role of DNA methylation and epigenetic silencing of HAND2 in endometrial cancer development. PLoS Med (2013) 1.10
A systems-level integrative framework for genome-wide DNA methylation and gene expression data identifies differential gene expression modules under epigenetic control. Bioinformatics (2014) 1.09
Epigenetic modulators, modifiers and mediators in cancer aetiology and progression. Nat Rev Genet (2016) 1.07
Down-regulation of CXCL12 mRNA expression by promoter hypermethylation and its association with metastatic progression in human breast carcinomas. J Cancer Res Clin Oncol (2008) 1.05
Wnt activity and basal niche position sensitize intestinal stem and progenitor cells to DNA damage. EMBO J (2015) 1.04
Aberrant methylation of CXCL12 in non-small cell lung cancer is associated with an unfavorable prognosis. Int J Oncol (2008) 0.98
Distinctive topology of age-associated epigenetic drift in the human interactome. Proc Natl Acad Sci U S A (2013) 0.94
Patterns of human gene expression variance show strong associations with signaling network hierarchy. BMC Syst Biol (2010) 0.93
DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancer. Nat Commun (2016) 0.93
Expression of CXCL14 and its anticancer role in breast cancer. Breast Cancer Res Treat (2012) 0.93
Signalling entropy: A novel network-theoretical framework for systems analysis and interpretation of functional omic data. Methods (2014) 0.91
Cis-regulatory somatic mutations and gene-expression alteration in B-cell lymphomas. Genome Biol (2015) 0.90
Epigenetic silencing of CXCL14 induced colorectal cancer migration and invasion. Discov Med (2013) 0.89
An integrative pan-cancer-wide analysis of epigenetic enzymes reveals universal patterns of epigenomic deregulation in cancer. Genome Biol (2015) 0.87
Abnormal hypermethylation of promoter region downregulates chemokine CXC ligand 14 expression in gastric cancer. Int J Oncol (2013) 0.86
Increased signaling entropy in cancer requires the scale-free property of protein interaction networks. Sci Rep (2015) 0.79
Network-based analysis identifies epigenetic biomarkers of esophageal squamous cell carcinoma progression. Bioinformatics (2014) 0.78